About two years ago Howard joined a clinical drug trial for Alzheimer's disease. The drug he received, now known as Flurizan, has just entered phase three of the drug trial. See this video to learn more...
There are nine new Alzheimer's treatments in phase three trials-the final step before FDA approval. All offering hope to either slow down or prevent the onset of Alzheimer's.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment